{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:00:54Z","timestamp":1780426854486,"version":"3.54.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>\n                    Several assays have been used to monitor tacrolimus levels. Automated immunoassay systems are preferred routinely because of their simplicity and rapid turnaround times. However, variations in the measured results for the same sample by different assays necessitate the evaluation of various immunoassay systems for consistency. This study aimed to compare whole-blood tacrolimus concentrations measured using 2 different chemiluminescence analytical methods: chemiluminescent microparticle immunoassay (CMIA; Abbott Diagnostics) and chemiluminescent immunoassay (CLIA; Snibe Diagnostics). A total of 257 patients who had undergone kidney transplantation were included in this study. Whole-blood tacrolimus concentrations were measured using the MAGLUMI 800 analyzer and compared with the ARCHITECT i1000SR analyzer using correlation analysis and Bland-Altman plots. There was a strong correlation between tacrolimus concentrations measured using MAGLUMI and those measured using ARCHITECT (\n                    <jats:italic toggle=\"yes\">R<\/jats:italic>\n                    \u2005=\u20050.916,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). An intraclass correlation coefficient (ICC) value of 0.934 (CI\u2005=\u20050.915\u20130.949) indicated excellent reliability of the measurements. Comparison of samples with a routine ARCHITECT assay for tacrolimus showed a minimal bias of 0.385\u2009ng\/mL (95% CI = 4.46%\u20133.69%), but scattering analysis indicated that the method agreed when the tacrolimus levels were low but disagreed at high levels. Overall, the measured tacrolimus level in patient samples was higher by MAGLUMI than by ARCHITECT with a median difference of 0.17\u2009ng\/mL and a median percentage difference of 3.4% respectively. Snibe MAGLUMI is a reliable assay with excellent correlation, but a small positive bias against Abbott ARCHITECT in measuring whole-blood tacrolimus levels. This bias is most likely due to the cross-reactivity of the metabolites in the Snibe MAGLUMI platform.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044895","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:02:30Z","timestamp":1759248150000},"page":"e44895","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Tacrolimus (FK-506) levels determined by 2 different chemiluminescence immunoassay-based analytical methods: A comparative cross-sectional study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9092-4957","authenticated-orcid":false,"given":"Vijay Kumar","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-7969","authenticated-orcid":false,"given":"Apeksha","family":"Niraula","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eans Tara","family":"Tuladhar","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0136-2524","authenticated-orcid":false,"given":"Raju Kumar","family":"Dubey","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem","family":"Bhattarai","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithileshwer","family":"Raut","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-6068","authenticated-orcid":false,"given":"Anuradha","family":"Kadel","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Kharal","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijana","family":"Sapkota","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Pokhrel","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Institute of Medicine, Maharajgunj Medical Campus, Kathmandu, Nepal."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"973564","DOI":"10.3389\/fphar.2022.973564","article-title":"Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence.","volume":"13","author":"Kostalova","year":"2022","journal-title":"Front Pharmacol"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1093\/labmed\/lmx056","article-title":"Tacrolimus: a review of laboratory detection methods and indications for use.","volume":"48","author":"Kalt","year":"2017","journal-title":"Lab Med"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/17425255.2023.2250251","article-title":"Individualized dosing algorithms for tacrolimus in kidney transplant recipients: current status and unmet needs.","volume":"19","author":"Schagen","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.leukres.2017.02.006","article-title":"Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.","volume":"57","author":"Gao","year":"2017","journal-title":"Leuk Res"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"e24958","DOI":"10.1002\/jcla.24958","article-title":"Determination of tacrolimus in human whole blood in kidney transplant recipients using a rapid and specific LC\u2013MS\/MS method.","volume":"37","author":"Hieu","year":"2023","journal-title":"J Clin Lab Anal"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/bcp.16098","article-title":"Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve-based monitoring?","volume":"91","author":"van Gelder","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/TP.0000000000003350","article-title":"Thirty years of tacrolimus in clinical practice.","volume":"105","author":"Ong","year":"2021","journal-title":"Transplantation"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report.","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12882-023-03188-0","article-title":"Higher tacrolimus trough levels and time in the therapeutic range are associated with the risk of acute rejection in the first month after renal transplantation.","volume":"24","author":"Nguyen","year":"2023","journal-title":"BMC Nephrol"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/labmed\/lmw032","article-title":"Evaluation of 2 batched pretreatment systems for the measurement of whole blood tacrolimus on the ARCHITECT immunoassay analyzer.","volume":"47","author":"Albeiroti","year":"2016","journal-title":"Lab. Med"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"e22587","DOI":"10.1002\/jcla.22587","article-title":"Comparison of whole\u2010blood tacrolimus concentrations measured by different immunoassay systems.","volume":"32","author":"Kaneko","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research.","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.clinbiochem.2005.02.011","article-title":"Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.","volume":"38","author":"Akbas","year":"2005","journal-title":"Clin Biochem"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/FTD.0b013e31819c6a37","article-title":"Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.","volume":"31","author":"Wallemacq","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.2042-7158.2010.01148.x","article-title":"Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values.","volume":"62","author":"Doki","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchromb.2018.04.028","article-title":"Simultaneous determination of cyclosporine and tacrolimus in human whole blood by ultra-high performance liquid chromatography tandem mass spectrometry and comparison with a chemiluminescence microparticle immunoassay.","volume":"1087-1088","author":"Mei","year":"2018","journal-title":"J Chromatogr B"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jpba.2010.06.022","article-title":"Evaluation of the Architect\u00ae tacrolimus assay in kidney, liver, and heart transplant recipients.","volume":"53","author":"Bazin","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/0091270009352188","article-title":"Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.","volume":"50","author":"Marubashi","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/bbrc.1994.1947","article-title":"Interaction of tacrolimus (FK506) and its metabolites with FKBP and calcineurin.","volume":"202","author":"Tamura","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20260602","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/clinchem\/42.9.1426","article-title":"Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients.","volume":"42","author":"Gonschior","year":"1996","journal-title":"Clin Chem"},{"key":"R24-20260602","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0009-9120(98)00086-1","article-title":"Tacrolimus metabolite cross-reactivity in different tacrolimus assays.","volume":"31","author":"Murthy","year":"1998","journal-title":"Clin Biochem"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/clinchem\/44.9.1942","article-title":"Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients.","volume":"44","author":"Cogill","year":"1998","journal-title":"Clin Chem"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1093\/clinchem\/44.12.2516","article-title":"Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography\u2013tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).","volume":"44","author":"Armstrong","year":"1998","journal-title":"Clin Chem"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/FTD.0b013e318279dfd2","article-title":"Low plasma concentrations of albumin influence the affinity column\u2013mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.","volume":"35","author":"Tempestilli","year":"2013","journal-title":"Ther Drug Monit"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/17425255.2017.1395413","article-title":"Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients.","volume":"13","author":"Andrews","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/ctr.12305","article-title":"Long-term evaluation of analytical methods used in sirolimus therapeutic drug monitoring.","volume":"28","author":"Holt","year":"2014","journal-title":"Clin Transplant"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3343\/alm.2018.38.2.85","article-title":"Multi-center performance evaluations of tacrolimus and cyclosporine electrochemiluminescence immunoassays in the asia-pacific region.","volume":"38","author":"Qin","year":"2018","journal-title":"Ann Lab Med"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/FTD.0000000000000269","article-title":"Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice: recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee.","volume":"38","author":"Seger","year":"2016","journal-title":"Ther Drug Monit"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2009.09.009","article-title":"Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS\/MS) and Abbott IMx methods.","volume":"410","author":"De","year":"2009","journal-title":"Clin Chim Acta"},{"key":"R33-20260602","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1093\/ajcp\/aqae129.397","article-title":"Comparison of five tacrolimus measurement methods underscore the need for a standardized method to improve clinical outcomes.","volume":"162","author":"Bandar","year":"2024","journal-title":"Am J Clin Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:02:18Z","timestamp":1780423338000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":30,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044895","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2024-10-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}